JP2019536470A5

JP2019536470A5 -

Download PDF

Info

Publication number: JP2019536470A5
Authority: JP; Japan
Prior art keywords: seq; tumor; pharmaceutical composition; monoclonal antibody; subject
Prior art date: 2017-09-21
Legal status : Granted

Application number

JP2019537042A

Other languages

English (en)

Japanese (ja)

Other versions

JP7069177B2 (ja

JP2019536470A6 (ja

JP2019536470A (ja

Filing date

2017-09-21

Publication date

2020-02-13

2017-09-21 Application filed filed Critical

2017-09-21 Priority claimed from PCT/US2017/052714 external-priority patent/WO2018057735A1/en

2019-12-19 Publication of JP2019536470A publication Critical patent/JP2019536470A/ja

2020-02-13 Publication of JP2019536470A5 publication Critical patent/JP2019536470A5/ja

2020-02-27 Publication of JP2019536470A6 publication Critical patent/JP2019536470A6/ja

2022-05-02 Priority to JP2022075712A priority Critical patent/JP7382444B2/ja

2022-05-17 Application granted granted Critical

2022-05-17 Publication of JP7069177B2 publication Critical patent/JP7069177B2/ja

2023-11-06 Priority to JP2023189126A priority patent/JP7720375B2/ja

Status Active legal-status Critical Current

2037-09-21 Anticipated expiration legal-status Critical

Links

230000027455 binding Effects 0.000 claims description 43
239000012634 fragment Substances 0.000 claims description 42
101000709472 Homo sapiens Sialic acid-binding Ig-like lectin 15 Proteins 0.000 claims description 38
102100034361 Sialic acid-binding Ig-like lectin 15 Human genes 0.000 claims description 38
239000000427 antigen Substances 0.000 claims description 38
108091007433 antigens Proteins 0.000 claims description 38
102000036639 antigens Human genes 0.000 claims description 38
239000008194 pharmaceutical composition Substances 0.000 claims description 34
206010028980 Neoplasm Diseases 0.000 claims description 30
210000004981 tumor-associated macrophage Anatomy 0.000 claims description 15
230000001404 mediated effect Effects 0.000 claims description 12
230000028993 immune response Effects 0.000 claims description 11
206010062016 Immunosuppression Diseases 0.000 claims description 10
210000001744 T-lymphocyte Anatomy 0.000 claims description 10
230000001506 immunosuppresive effect Effects 0.000 claims description 10
230000000694 effects Effects 0.000 claims description 7
239000000546 pharmaceutical excipient Substances 0.000 claims description 7
230000001629 suppression Effects 0.000 claims description 6
230000004614 tumor growth Effects 0.000 claims description 5
239000000203 mixture Substances 0.000 claims description 4
125000003275 alpha amino acid group Chemical group 0.000 claims 12
206010025323 Lymphomas Diseases 0.000 claims 4
206010061535 Ovarian neoplasm Diseases 0.000 claims 4
230000006052 T cell proliferation Effects 0.000 claims 4
208000029742 colonic neoplasm Diseases 0.000 claims 4
230000001934 delay Effects 0.000 claims 4
230000001737 promoting effect Effects 0.000 claims 4
238000000034 method Methods 0.000 description 29
210000004027 cell Anatomy 0.000 description 18
150000001413 amino acids Chemical group 0.000 description 14
108020001507 fusion proteins Proteins 0.000 description 11
102000037865 fusion proteins Human genes 0.000 description 11
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
239000003446 ligand Substances 0.000 description 6
229920001184 polypeptide Polymers 0.000 description 6
108090000765 processed proteins & peptides Proteins 0.000 description 6
102000004196 processed proteins & peptides Human genes 0.000 description 6
238000003556 assay Methods 0.000 description 5
230000004927 fusion Effects 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
210000001519 tissue Anatomy 0.000 description 5
108010047041 Complementarity Determining Regions Proteins 0.000 description 4
102000009109 Fc receptors Human genes 0.000 description 4
108010087819 Fc receptors Proteins 0.000 description 4
208000035475 disorder Diseases 0.000 description 4
230000004044 response Effects 0.000 description 4
102100022187 Leucine-rich repeat-containing protein 4C Human genes 0.000 description 3
101710084185 Leucine-rich repeat-containing protein 4C Proteins 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
201000010099 disease Diseases 0.000 description 3
210000002540 macrophage Anatomy 0.000 description 3
238000012544 monitoring process Methods 0.000 description 3
210000002997 osteoclast Anatomy 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
208000009329 Graft vs Host Disease Diseases 0.000 description 2
102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
206010052779 Transplant rejections Diseases 0.000 description 2
230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000004540 complement-dependent cytotoxicity Effects 0.000 description 2
239000002254 cytotoxic agent Substances 0.000 description 2
229940127089 cytotoxic agent Drugs 0.000 description 2
231100000599 cytotoxic agent Toxicity 0.000 description 2
239000003814 drug Substances 0.000 description 2
230000002349 favourable effect Effects 0.000 description 2
208000024908 graft versus host disease Diseases 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
230000028327 secretion Effects 0.000 description 2
230000019491 signal transduction Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
208000023275 Autoimmune disease Diseases 0.000 description 1
208000006386 Bone Resorption Diseases 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
102000003886 Glycoproteins Human genes 0.000 description 1
108090000288 Glycoproteins Proteins 0.000 description 1
102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
230000008468 bone growth Effects 0.000 description 1
230000024279 bone resorption Effects 0.000 description 1
230000016396 cytokine production Effects 0.000 description 1
210000004443 dendritic cell Anatomy 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
229940079593 drug Drugs 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
210000004881 tumor cell Anatomy 0.000 description 1

Images

JP2019537042A 2016-09-21 2017-09-21 シグレック－１５に対する抗体及びその使用方法 Active JP7069177B2 (ja)